Qyuns Therapeutics Co., Ltd. (HKG:2509)

Qyuns Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	325.09	961.75	360.69	216.3	213.09	218.06
Short-Term Investments	295.84	80.86	0.42	0.54	0.55	0.29
Trading Asset Securities	421.44	-	195.44	160.41	401.1	402.38
Cash & Short-Term Investments	1,042	1,043	556.55	377.26	614.73	620.72
Cash Growth	86.50%	87.33%	47.53%	-38.63%	-0.97%	-
Accounts Receivable	96.11	19.7	26.28	-	-	-
Other Receivables	1.33	0.18	0.6	0.36	4.04	8.65
Receivables	97.44	19.87	26.88	0.36	4.04	8.65
Inventory	63.95	8.45	3.34	3.77	-	-
Prepaid Expenses	41.6	16.13	24.52	23.03	16.23	18.45
Other Current Assets	86.02	29.61	5.44	13.91	0.94	0.44
Total Current Assets	1,333	1,117	616.73	418.33	635.95	648.26
Property, Plant & Equipment	305.83	309.83	334.06	361.44	386.16	400.83
Long-Term Investments	233.07	134.86	-	-	-	-
Other Intangible Assets	2.06	2.46	3.47	2.35	3.05	0.38
Other Long-Term Assets	36.58	36.51	29.62	13.47	9.94	18.02
Total Assets	1,911	1,600	983.88	795.58	1,035	1,067

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	142.84	96.72	110.89	72.96	19.14	12.6
Accrued Expenses	25.28	43.79	33.37	31.01	24.64	19.04
Short-Term Debt	39.63	29.8	179.48	59.6	15.9	-
Current Portion of Long-Term Debt	174.05	148.15	31.1	60.1	44.61	14.87
Current Portion of Leases	0.95	1.27	1.42	1.29	1.75	0.96
Current Unearned Revenue	79.24	44.53	9.36	0.87	-	-
Other Current Liabilities	119.48	139.48	64.54	25.95	16.15	22.22
Total Current Liabilities	581.48	503.74	430.16	251.78	122.19	69.67
Long-Term Debt	470.84	399.45	315.12	224.43	232.52	274.05
Long-Term Leases	1.03	1.34	0.47	0.63	0.47	0.39
Long-Term Unearned Revenue	16.03	16.44	16.73	17.38	18.02	18.66
Long-Term Deferred Tax Liabilities	0.23	0.27	0.34	0.41	0.49	0.56
Total Liabilities	1,070	921.23	762.83	494.63	373.69	363.33

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	227.07	227.07	222.07	210.03	180.53	166.48
Additional Paid-In Capital	-	1,098	1,012	830.18	830.18	616.23
Retained Earnings	-	-942.48	-1,257	-921.36	-413.61	-115.42
Treasury Stock	-	-27.19	-	-	-	-
Comprehensive Income & Other	633.95	338.2	251.37	175.91	44.62	3.06
Total Common Equity	861.02	694.03	228.98	294.76	641.72	670.35
Minority Interest	-19.68	-14.93	-7.93	6.19	19.7	33.82
Shareholders' Equity	841.35	679.1	221.05	300.95	661.41	704.17
Total Liabilities & Equity	1,911	1,600	983.88	795.58	1,035	1,067

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	686.51	580.01	527.6	346.06	295.25	290.26
Net Cash (Debt)	355.86	462.6	28.96	31.2	319.48	330.46
Net Cash Growth	-	1497.61%	-7.18%	-90.23%	-3.32%	-
Net Cash Per Share	1.58	2.07	0.13	0.15	1.80	2.84
Filing Date Shares Outstanding	223.38	225.56	222.07	222.07	180.53	166.48
Total Common Shares Outstanding	223.38	225.56	222.07	210.03	180.53	166.48
Working Capital	751.94	612.93	186.56	166.55	513.76	578.59
Book Value Per Share	3.85	3.08	1.03	1.40	3.55	4.03
Tangible Book Value	858.96	691.57	225.5	292.42	638.66	669.98
Tangible Book Value Per Share	3.85	3.07	1.02	1.39	3.54	4.02
Buildings	-	238.61	238.61	238.73	238.73	238.73
Machinery	-	195.06	190.77	188.24	178.24	168.09
Construction In Progress	-	0.07	0.43	0.21	4.96	2.01

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error